{"DataElement":{"publicId":"5097014","version":"1","preferredName":"Laboratory Procedure HLA-A2 Outcome Category","preferredDefinition":"The positive/negative indicator that asks the status of the procedure that involves testing the HLA class I histocompatibility antigen, A-2 alpha chain (365 aa, ~41 kDa).","longName":"LAB_PROC_HLA_A2_CAT","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"5097013","version":"1","preferredName":"Laboratory Procedure HLA-A2 Outcome","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._HLA class I histocompatibility antigen, A-2 alpha chain (365 aa, ~41 kDa) is encoded by the human HLA-A gene. This protein is involved in antigen presentation._The result of an action.","longName":"2543047v1.0:5097011v1.0","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5097011","version":"1","preferredName":"HLA Class I Histocompatibility Antigen, A-2 Alpha Chain Outcome","preferredDefinition":"HLA class I histocompatibility antigen, A-2 alpha chain (365 aa, ~41 kDa) is encoded by the human HLA-A gene. This protein is involved in antigen presentation.:The result of an action.","longName":"C16691:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HLA Class I Histocompatibility Antigen, A-2 Alpha Chain","conceptCode":"C16691","definition":"HLA class I histocompatibility antigen, A-2 alpha chain (365 aa, ~41 kDa) is encoded by the human HLA-A gene. This protein is involved in antigen presentation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28AEF6EA-F356-2079-E050-BB89AD4316E2","latestVersionIndicator":"Yes","beginDate":"2016-01-06","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-01-06","modifiedBy":"ONEDATA","dateModified":"2016-01-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"28AEF6EA-F367-2079-E050-BB89AD4316E2","latestVersionIndicator":"Yes","beginDate":"2016-01-06","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-01-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Curated for MDA2014-04-02 bsm","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3911843","version":"1","preferredName":"Positive Negative Not Done Category","preferredDefinition":"Involving advantage or good._Negative; not indicating the presence of microorganisms or disease or a specific condition._Category; used informally to mean a class of things.","longName":"POS_NEG_ND_CAT","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Negative","valueDescription":"Negative Finding","ValueMeaning":{"publicId":"2617835","version":"1","preferredName":"Negative Finding","longName":"2617835","preferredDefinition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2CAF63D8-1F72-70DF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-03-27","modifiedBy":"DWARZEL","dateModified":"2022-10-03","changeDescription":"Updated VM Short Name to be the Public ID to be consistent with current convention for VM Short Name - DW 10-03-2022","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E79FC127-EA80-3F7F-E040-BB89AD430F6F","beginDate":"2013-08-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-30","modifiedBy":"ONEDATA","dateModified":"2013-09-30","deletedIndicator":"No"},{"value":"Positive","valueDescription":"Positive Finding","ValueMeaning":{"publicId":"2840097","version":"1","preferredName":"Positive Finding","longName":"2840097","preferredDefinition":"An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"635F3981-C763-F359-E040-BB89AD435EC5","latestVersionIndicator":"Yes","beginDate":"2009-02-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-20","modifiedBy":"KUMMEROA","dateModified":"2023-08-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E79FC127-EA8A-3F7F-E040-BB89AD430F6F","beginDate":"2013-08-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-30","modifiedBy":"ONEDATA","dateModified":"2013-09-30","deletedIndicator":"No"},{"value":"Not Done","valueDescription":"Not Done","ValueMeaning":{"publicId":"3104692","version":"1","preferredName":"Not Done","longName":"3104692v1.00","preferredDefinition":"Indicates a task, process or examination that has either not been initiated or not been completed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88084310-6796-6259-E040-BB89AD4311C3","latestVersionIndicator":"Yes","beginDate":"2010-06-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-02","modifiedBy":"RAGUNATHANU","dateModified":"2022-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E79FC127-EA94-3F7F-E040-BB89AD430F6F","beginDate":"2013-08-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-30","modifiedBy":"ONEDATA","dateModified":"2013-09-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3911842","version":"1","preferredName":"Positive Negative Finding Category","preferredDefinition":"Involving advantage or good.:A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.:Category; used informally to mean a class of things.","longName":"C25246:C38757:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive","conceptCode":"C25246","definition":"Involving advantage or good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E79FC127-EA5C-3F7F-E040-BB89AD430F6F","latestVersionIndicator":"Yes","beginDate":"2013-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-30","modifiedBy":"ONEDATA","dateModified":"2013-09-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E79FC127-EA6D-3F7F-E040-BB89AD430F6F","latestVersionIndicator":"Yes","beginDate":"2013-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-30","modifiedBy":"TAYLORT","dateModified":"2017-08-24","changeDescription":"8/24/17 tt VD used by a Standard CDE and changes must be consistent with C3D format requirements; added CRF CSI and changed reg status per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"5441476","version":"1","longName":"MDA2014-04-02","context":"DCP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"HLA-A2 Status","type":"Preferred Question Text","description":"HLA-A2 Status","url":null,"context":"DCP"},{"name":"DCP Question","type":"Alternate Question Text","description":"HLA-A2 Status","url":null,"context":"DCP"}],"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"28AEF6EA-F37A-2079-E050-BB89AD4316E2","latestVersionIndicator":"Yes","beginDate":"2016-01-06","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-01-06","modifiedBy":"SOKKERL","dateModified":"2016-12-19","changeDescription":"Curated for MDA2014-02-02 bsm.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}